AbbVie Inc. (ABBV): stock score 62/100

AbbVie Inc. (ABBV) scores 62 out of 100 (above average among 99 US stocks) on trend, stability, fundamentals, market backdrop and news tone. Every calculation step shown. Educational, not advice.

ABBV scores 62.3 out of 100 (above average), up 13.4 points from last week. Its news tone adds the most (+7.6 points: average FinBERT sentiment +0.353 over 59 articles). Its stability weighs on it most (-0.6 points: forecast 25.1% vs normal 24.0%). Our research found no proven record of these factors predicting returns.

How the score is built

Trend: 72/100 (+4.3 points)

1. Price is +13.0% vs its 100-day average → higher than 86% of the comparison group → 86
2. 12-1 month momentum +17.3% → higher than 57% of the comparison group → 57
3. Average of the two → trend score 71.7

Tested in our research: the trend rule did not hold up out of sample.

Stability: 47/100 (-0.6 points)

1. Forecast 25.1% vs normal 24.0% → ratio 1.05
2. Ratio is higher than 53% of the comparison group → 100 minus 53 → stability 47.0 (bigger expected swings than usual → lower stability)

A machine-learning volatility model beat HAR for the S&P 500 (p = 0.04); not yet tested on single stocks. This component uses HAR.

Fundamentals: 54/100 (+0.8 points)

1. Revenue growth vs a year earlier: +11.2% → higher than 65% of the comparison group → 65
2. Operating-margin change vs a year earlier: +2.6 pp → higher than 83% of the comparison group → 83
3. Change in leverage (1 - equity/assets) vs a year earlier: +4.3 pp → higher than 13% of the comparison group (lower is better) → 13
4. Average of available items → fundamentals score 54.0

Not yet tested in our research.

Market backdrop: 51/100 (+0.2 points)

1. VIX in its 5-year range: 60 after inverting (lower VIX → higher)
2. Breadth vs its 5-year range → 45
3. Credit trend vs its 5-year range → 15
4. Yield curve vs its 5-year range → 83
5. Average → backdrop score 50.8 (same for every stock)

Tested in our research: cross-asset indicators did not improve forecasts.

News tone: 88/100 (+7.6 points)

1. Average FinBERT sentiment +0.353 over 59 articles; shrunk towards 0 for few articles → tone +0.325
2. Tone vs this stock's own past year → news score 87.9

Tested in our research: news sentiment made predictions slightly worse.

ABBV score history (weekly)

Health care stocks compared

• ABBV: 62/100
• AMGN: 62/100
• LLY: 60/100
• MMM: 59/100
• BIIB: 58/100
• GILD: 54/100
• PFE: 50/100
• BMY: 50/100
• UNH: 49/100
• MDT: 48/100
• MRK: 37/100
• ABT: 36/100
• JNJ: 36/100

Questions

What is AbbVie Inc.'s (ABBV) Quantooo score today?

ABBV scores 62 out of 100 on 2026-10-22, above average among 99 US stocks. It ranks 13th of 99 overall and 1st of 13 in Health care. It was 49 a week earlier.

What raises and lowers ABBV's score?

News tone adds the most (88/100, +7.6 points) and stability weighs on it most (47/100, -0.6 points). The score is 50 plus each part's weighted distance from 50.

Is ABBV stock volatile right now?

Our volatility model (HAR) expects annualised swings of 25.1% over the next 20 trading days, against a normal level of 24.0% for ABBV: bumpier than usual for this stock. Its stability score is 47/100 compared with the other 99 US stocks.

How are AbbVie Inc.'s fundamentals changing?

Revenue growth vs a year earlier: +11.2%; Operating-margin change vs a year earlier: +2.6 pp; Change in leverage (1 - equity/assets) vs a year earlier: +4.3 pp. Fundamentals score: 54/100. From the 10-Q filed 2026-08-03 (period to 2026-06-30).

Does the score predict ABBV's share price?

No. The score describes the stock's recent data; it is not a forecast of the share price. Our own tests found no reliable ability to rank stocks by future returns, and every test, including the failures, is published. Educational, not investment advice.

Sector: Health care. Data as of 2026-10-22. Scores describe data; they are not recommendations or predictions. Educational, not investment advice.